Noveome Biotherapeutics
PrivateLast Round
Series E
Apr 23, 2025
Total Funding Raised
$185.5M
Company Overview
Noveome Biotherapeutics is a biotechnology company that develops novel biotherapeutic products aimed at treating inflamed or damaged tissues through a synergistic combination of biologic components.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Noveome Biotherapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Noveome Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Apr 23, 2025 | ||||
| Grant | Jun 23, 2021 | ||||
| Grant | May 7, 2020 | ||||
| Series D | Apr 9, 2019 | ||||
| Grant | Apr 3, 2018 |
Key People
Founding team and executive leadership
Noveome Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Pittsburgh Investment Office | Seed |
| Carnegie Mellon University Investment Office | Seed |
| Miraki | Series E |
| U.S. Department of War | Grant |
| Commonwealth of Pennsylvania | Grant |
| MAK Capital One | Series E |
| Lancet Capital | Seed |
Noveome Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Noveome Biotherapeutics's valuation, stock price, and market status.